SINTX Technologies Receives USPTO Notice of Allowance for Silicon Nitride Antipathogenic Platform Patent
1. SINTX receives patent for silicon nitride antipathogen platform. 2. Patent enhances SINTX's position in the $30 billion infection-prevention market. 3. Technology could significantly reduce healthcare-associated infection costs and patient stays. 4. SINTX plans partnerships for product commercialization in healthcare applications.